RecommendationAt initial assessment, offer men with LUTS a urine dipstick test to detect blood, glucose, protein, leucocytes and nitrites.
Relative values of different outcomesThe GDG considered that detection of diabetes, bladder cancer, renal disease, urinary tract infections and urinary tract stones were the primary outcomes of interest.
Trade off between clinical benefits and harmsThe test is non-invasive and has no known side effects. The benefit of detecting cases of bladder cancer was considered to be very important.
Economic considerationsThere are costs associated with additional specialised tests required after a positive result of this test. However, missed cases are associated with costs and health detriment that is likely to outweigh the cost of false positives.
Quality of evidenceOne low quality study was found in an indirect population. The study reported the accuracy of erythrocytes sediment detection from urinalysis which is only one component of a urine dipstick test.
This recommendation was mainly based on expert opinion due to the limitations of the study retrieved.
Other considerationsThis recommendation is linked to the one on medical history as specific pre-existing conditions may have an impact on the interpretation of results of urinalysis.

From: 4, Diagnosis

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.